Fitness & Wellness · national
New pancreatic cancer drug shrinks tumors in majority of patients
A new drug stopped tumor growth in more than 60% of patients in an early study.
A new pancreatic cancer drug showed promise in an early study, according to WFLA 8. Researchers tested the drug on 60 patients and found it shrank tumors in more than 60% of them.
The drug made cancer completely undetectable in 8% of the patients studied, WFLA 8 reported. The results suggest the medication may help some people with pancreatic cancer, though more research is needed to confirm its safety and effectiveness in larger groups.
What it means in Raleigh
RALEIGH HEALTH SYSTEM
State agency: NC Department of Health and Human Services (NCDHHS)
Behavioral health: Alliance Health (LME/MCO for Wake, Durham, Johnston, Orange, Cumberland, Mecklenburg)
Medicaid plans: NC Medicaid Standard Plans: AmeriHealth Caritas NC, Carolina Complete Health, Healthy Blue, UnitedHealthcare Community Plan, WellCare of NC. Tailored Plans: Alliance Health, Trillium Health Resources, Vaya Partners (Vaya Health + Partners Health Management, merged 2026).
Major insurers: Blue Cross NC, Aetna, Cigna, UnitedHealthcare, Humana
Plan lists change; confirm with your plan or the state agency.
Behavioral health: Alliance Health (LME/MCO for Wake, Durham, Johnston, Orange, Cumberland, Mecklenburg)
Medicaid plans: NC Medicaid Standard Plans: AmeriHealth Caritas NC, Carolina Complete Health, Healthy Blue, UnitedHealthcare Community Plan, WellCare of NC. Tailored Plans: Alliance Health, Trillium Health Resources, Vaya Partners (Vaya Health + Partners Health Management, merged 2026).
Major insurers: Blue Cross NC, Aetna, Cigna, UnitedHealthcare, Humana
Plan lists change; confirm with your plan or the state agency.
Sources
Not medical advice. HLA Network News reports health news. Talk to your doctor or care team about your own care. In a crisis, call or text 988. In an emergency, call 911.
